152 related articles for article (PubMed ID: 38370381)
1. Gene polymorphisms of
Zhang S; Liu S; Chen W; Yan Y; Cai M; Liu X; Luo A; Li W; Yi L; Xu Y
J Cancer; 2024; 15(6):1762-1769. PubMed ID: 38370381
[No Abstract] [Full Text] [Related]
2. Relationship between PIWIL1 gene polymorphisms and epithelial ovarian cancer susceptibility among southern Chinese woman: a three-center case-control study.
Liu S; Yan Y; Cui Z; Feng H; Zhong F; Liu Z; Li Y; Ou X; Li W
BMC Cancer; 2023 Nov; 23(1):1149. PubMed ID: 38012622
[TBL] [Abstract][Full Text] [Related]
3. METTL16 Inhibits the Malignant Progression of Epithelial Ovarian Cancer through the lncRNA MALAT1/
Li C; Liu J; Lyu Y; Ling S; Luo Y
Anal Cell Pathol (Amst); 2023; 2023():9952234. PubMed ID: 37927399
[TBL] [Abstract][Full Text] [Related]
4. Clinical Significance of Methyltransferase-like 16 Expression in Epithelial Ovarian Cancer.
Li C; Qiao C; Ding H; Luo Y
J Coll Physicians Surg Pak; 2022 Dec; 32(12):1576-1580. PubMed ID: 36474378
[TBL] [Abstract][Full Text] [Related]
5. Role of DNA repair and cell cycle control genes in ovarian cancer susceptibility.
Mohamed FZ; Hussien YM; AlBakry MM; Mohamed RH; Said NM
Mol Biol Rep; 2013 May; 40(5):3757-68. PubMed ID: 23277402
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in IGF2/H19 gene locus are associated with platinum-based chemotherapeutic response in Chinese patients with epithelial ovarian cancer.
Zeng Y; Li TL; Zhang HB; Deng JL; Zhang R; Sun H; Wan ZR; Liu YZ; Zhu YS; Wang G
Pharmacogenomics; 2019 Feb; 20(3):179-188. PubMed ID: 30672383
[TBL] [Abstract][Full Text] [Related]
7. Correlation between polymorphisms in IGF2/H19 gene locus and epithelial ovarian cancer risk in Chinese population.
Zhang HB; Zeng Y; Li TL; Wang G
Genomics; 2020 May; 112(3):2510-2515. PubMed ID: 32045670
[TBL] [Abstract][Full Text] [Related]
8. The effect of polymorphisms in PD-1 gene on the risk of epithelial ovarian cancer and patients' outcomes.
Li Y; Zhang HL; Kang S; Zhou RM; Wang N
Gynecol Oncol; 2017 Jan; 144(1):140-145. PubMed ID: 27836206
[TBL] [Abstract][Full Text] [Related]
9. New association between splicing factor-coding gene polymorphisms and the risk of acute lymphoblastic leukemia in southern Chinese children: A five-center case-control study.
Deng D; Luo A; Li M; Yan Y; Cai M; Liu S; Liu X; Wang X; Zhang X; Jiang H; Liu X
J Gene Med; 2023 Apr; 25(4):e3474. PubMed ID: 36680332
[TBL] [Abstract][Full Text] [Related]
10. Associations between
Huang X; Shen C; Zhang Y; Li Q; Li K; Wang Y; Song Y; Su M; Zhou B; Wang W
Dis Markers; 2019; 2019():8012979. PubMed ID: 31485280
[TBL] [Abstract][Full Text] [Related]
11. Relationship of WNT4 Gene with the Risk of Epithelial Ovarian Cancer: A Han Chinese Population-Based Association Study.
Zhang J; Zhang P; Shen Y; Yang M; Zou H; Liu H
Genet Test Mol Biomarkers; 2018 Dec; 22(12):686-692. PubMed ID: 30457351
[TBL] [Abstract][Full Text] [Related]
12. METTL16, Methyltransferase-Like Protein 16: Current Insights into Structure and Function.
Ruszkowska A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671635
[TBL] [Abstract][Full Text] [Related]
13. Vascular Endothelial Growth Factor (VEGF) Polymorphisms and Serum VEGF Levels in Women With Epithelial Ovarian Cancer, Benign Tumors, and Healthy Ovaries.
González-Palomares B; Coronado Martín PJ; Maestro de Las Casas ML; Veganzones de Castro S; Rafael Fernández S; Vidaurreta Lázaro M; De la Orden García V; Vidart Aragon JA
Int J Gynecol Cancer; 2017 Jul; 27(6):1088-1095. PubMed ID: 28574932
[TBL] [Abstract][Full Text] [Related]
14. Prediction value of intercellular adhesion molecule-1 gene polymorphisms for epithelial ovarian cancer risk, clinical features, and prognosis.
Cai G; Ma X; Zou W; Huang Y; Zhang J; Wang D; Chen B
Gene; 2014 Aug; 546(1):117-23. PubMed ID: 23933413
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Gynecol Oncol; 2011 Sep; 122(3):554-9. PubMed ID: 21714991
[TBL] [Abstract][Full Text] [Related]
16. RIPK1 polymorphisms and expression levels: impact on genetic susceptibility and clinical outcome of epithelial ovarian cancer.
Wang X; Deng K; Tao J; Zou J; Du Y; Dai L
Cancer Cell Int; 2023 Nov; 23(1):290. PubMed ID: 37996860
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants and expression of the TIM-3 gene are associated with clinical prognosis in patients with epithelial ovarian cancer.
Wu JL; Zhao J; Zhang HB; Zuo WW; Li Y; Kang S
Gynecol Oncol; 2020 Oct; 159(1):270-276. PubMed ID: 32694063
[TBL] [Abstract][Full Text] [Related]
18. Association between
Zhang Y; Wang Y; Huang X; Li Q; Li K; You D; Song Y; Su M; Zhou B; Wang W
Biomark Med; 2019 Apr; 13(6):445-455. PubMed ID: 30929455
[No Abstract] [Full Text] [Related]
19. Role of common ERCC1 polymorphisms in cisplatin-resistant epithelial ovarian cancer patients: A study in Chinese cohort.
Bao Y; Yang B; Zhao J; Shen S; Gao J
Int J Immunogenet; 2020 Oct; 47(5):443-453. PubMed ID: 32173978
[TBL] [Abstract][Full Text] [Related]
20. Association between the rs11614913 variant of miRNA-196a-2 and the risk of epithelial ovarian cancer.
Song ZS; Wu Y; Zhao HG; Liu CX; Cai HY; Guo BZ; Xie YA; Shi HR
Oncol Lett; 2016 Jan; 11(1):194-200. PubMed ID: 26870188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
